Application | Comment | Organism |
---|---|---|
medicine | GCPII inhibitors are attractive candidates for clinical treatment trials in amylotrophic lateral sclerosis | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(3-mercaptopropyl)pentanedioic acid | orally bioavailable inhibitor | Rattus norvegicus | |
2-(phosphonomethyl)pentanedioic acid | requires long-term daily dosing | Rattus norvegicus | |
additional information | GCPII inhibitors are attractive candidates for clinical treatment trials in amylotrophic lateral sclerosis | Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-acetyl-Asp-Glu + H2O | Rattus norvegicus | - |
N-acetyl-Asp + Glu | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-acetyl-Asp-Glu + H2O | - |
Rattus norvegicus | N-acetyl-Asp + Glu | - |
? |
Synonyms | Comment | Organism |
---|---|---|
GCPII | - |
Rattus norvegicus |